NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in NextCure, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- +4 vs. Q1 2026
- Shares held
- 1.74M
- −434.3K (−20.0%) vs. Q1 2026
- Total value
- $2.78M
- −$20.2M (−87.9%) vs. Q1 2026
- New holders
- 11
- 8 more added
- Sold out
- 7
- 5 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NXTC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 30 | $2.78M |
| Q1 2026 | 26 | $23.0M |
| Q4 2025 | 24 | $26.9M |
| Q3 2025 | 17 | $5.03M |
| Q2 2025 | 30 | $5.65M |
| Q1 2025 | 38 | $7.38M |
| Q4 2024 | 46 | $13.1M |
| Q3 2024 | 44 | $21.7M |
| Q2 2024 | 49 | $25.5M |
| Q1 2024 | 47 | $36.0M |
| Q4 2023 | 43 | $15.3M |
| Q3 2023 | 41 | $16.6M |
| Q2 2023 | 43 | $24.0M |
| Q1 2023 | 44 | $19.6M |
| Q4 2022 | 45 | $18.9M |
| Q3 2022 | 52 | $41.8M |
| Q2 2022 | 51 | $67.9M |
| Q1 2022 | 59 | $64.3M |
| Q4 2021 | 71 | $86.2M |
| Q3 2021 | 71 | $99.5M |
| Q2 2021 | 78 | $124.2M |
| Q1 2021 | 92 | $179.8M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding NextCure, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 20 | $32 | 0.00% | +20 | New |
| BNP Paribas Arbitrage, SA | 32 | $51 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 66 | $106 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 61 | $107 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 83 | $133 | 0.00% | +83 | New |
| UBS Group AG | 594 | $951 | 0.00% | +256+75.7% | Added |
| Tower Research Capital LLC (TRC) | 1,738 | $2.78K | 0.00% | +1,738 | New |
| Persistent Asset Partners Ltd | 1,981 | $3.17K | 0.00% | +1,981 | New |
| Barclays PLC | 5,726 | $9.16K | 0.00% | +100+1.8% | Added |
| Diadema Partners LP | 7,742 | $12.4K | 0.00% | +7,742 | New |
| Virtu Financial LLC | 10,991 | $18.0K | 0.00% | +10,991 | New |
| Nomura Asset Management International Inc. | 12,500 | $20.0K | 0.00% | +12,500 | New |
| Vanguard Fiduciary Trust Co | 16,134 | $25.8K | 0.00% | +119+0.7% | Added |
| Acadian Asset Management LLC | 18,982 | $30.0K | 0.00% | 00.0% | Unchanged |
| Cardiff Park Advisors, LLC | 21,833 | $34.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 29,905 | $47.9K | 0.00% | −1,187−3.8% | Reduced |
| Jane Street Group, LLC | 32,725 | $52.4K | 0.00% | +32,725 | New |
| HRT Financial LP | 36,450 | $58.0K | 0.00% | +36,450 | New |
| BlackRock, Inc. | 37,348 | $59.8K | 0.00% | +9,555+34.4% | Added |
| Affinity Asset Advisors, LLC | 41,960 | $67.1K | 0.00% | −199,866−82.6% | Reduced |
| Pfizer Inc | 44,347 | $73.0K | 0.04% | −109,007−71.1% | Reduced |
| Verdad Advisers, LP | 60,451 | $96.7K | 0.09% | +17,496+40.7% | Added |
| Squadron Capital Management LLC | 64,464 | $103.1K | 0.04% | −200,536−75.7% | Reduced |
| Boothbay Fund Management, LLC | 84,687 | $135.5K | 0.00% | +15,070+21.6% | Added |
| Millennium Management LLC | 88,112 | $141.0K | 0.00% | +88,112 | New |
| Vanguard Capital Management LLC | 156,842 | $250.9K | 0.00% | −3,631−2.3% | Reduced |
| Renaissance Technologies LLC | 171,202 | $273.9K | 0.00% | +110,668+182.8% | Added |
| Sofinnova Investments, Inc. | 222,654 | $356.2K | 0.02% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 277,202 | $443.5K | 0.00% | +277,202 | New |
| Ikarian Capital, LLC | 288,303 | $461.3K | 0.08% | +50,000+21.0% | Added |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −176,057−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −141,181−100.0% | Sold out |
| AWM Investment Company, Inc. | 0 | $0 | 0.00% | −117,371−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −115,500−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −27,498−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −15,292−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |